CDK4 and neoplasm: In this regard, several studies of tumour cells treated with CDK4/6 inhibitors have demonstrated increased expression of cytokines such as CCL5, CXCL9, CXCL10 and IL-15 which are involved in the recruitment of CD8 + T cells [56, 126, 128, 134–136].